Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasmatherapy in atypical hemolytic uremic syndrome.

Seminars in thrombosis and hemostasis - 1 Sept 2010

Loirat Chantal, Garnier Arnaud, Sellier-Leclerc Anne-Laure, Kwon Theresa

Abstract excerpt

Plasmatherapy has become empirically first-line treatment in atypical hemolytic uremic syndrome (aHUS), although no prospective controlled trials have been conducted. Patients with mutations that induce complete or partial factor H (FH) quantitative deficiency may be controlled by plasma infusion...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement Factor H
Share to Fibrinogen
Share to Hemolytic-Uremic Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Failure, Chronic

Share to Membrane Cofactor Protein

Share to Plasma Exchange

Share to Time Factors

Share to Treatment Outcome

Source

Identifiers

PMID: 20865645
DOI: 10.1055/s-0030-1262890

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20865645-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasmatherapy in atypical hemolytic uremic syndrome.PMID 20865645Read ↗

Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.Semantic proximity Read ↗

Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome.Semantic proximity Read ↗

Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.Semantic proximity Read ↗

aHUS caused by complement dysregulation: new therapies on the horizon.Semantic proximity Read ↗

Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.Semantic proximity Read ↗

Complement dysfunction in hemolytic uremic syndrome.Semantic proximity Read ↗

How I diagnose and treat atypical hemolytic uremic syndromeSemantic proximity Read ↗

Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Complement therapy in atypical haemolytic uraemic syndrome (aHUS)Semantic proximity Read ↗

Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Haemolytic uraemic syndrome.Semantic proximity Read ↗

Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.